When your doctor talks to you about your B-cell lymphoma ... If you have this cancer, you make too much of a protein called immunoglobulin M (IgM). You may get symptoms such as bleeding easily ...

When this method was applied to WGS data it revealed that B cells producing IgM/D antibodies in the blood (produced when the body first encounters a foreign antigen) were the only type of B cell ...

A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free ...

which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies, IGM-8444, which is an IgM antibody targeting Death ...

IGM Biosciences Inc. said Thursday it is cutting ... lupus erythematosus “show that the depth and consistency of B cell depletion is insufficient to meet our high bar for success,” Mary ...

In yet another early year blow for the Bay Area’s biotech workforce, IGM Biosciences is laying off ... wrote that “the depth and consistency of B cell depletion is insufficient to meet our ...

Fred Locke, MD, Moffitt Cancer Center, explains why this hematologic cancer is such an attractive target for chimeric antigen ...

When this method was applied to WGS data it revealed that B cells producing IgM/D antibodies in the blood (produced when the body first encounters a foreign antigen) were the only type of B cell ...